Ta en i det andra benet också

Måttliga mängder öl och vin kan motverka benskörhet visar en ny studie.

El kan lindra Parkinson

Genom att stimulera nerver i ryggmärgen hoppas forskarna kunna minska medicindosen hos Parkinsonpatienter.

Från skogsindustriell forskning till mångvetenskapligt ledarskap: KTH-professor ska förnya finsk forskning

Hon kom till Sverige och KTH som gästprofessor för 13 år sedan. I april återvänder Tuula Teeri till Finland med akademiska meriter som professor och prorektor i bagaget. Den nya titeln är rektor för det tvärvetenskapliga Aalto-universitetet i Helsingfors.

Fet balans med nytt dataverktyg

Ett nytt EU-projekt ska ta fram modeller för att beräkna vilken effekt fet fisk, frukt och bär har på kroppen.

Scanbalt får ny medlem

Polska Biobaltica är det senaste tillskottet i paraplyorganisationen Scanbalt.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Harmony prevents dementia

People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

LEO Pharma - International Clinical Trial Manager

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.